Skip to main content
Top
Published in: Journal of Neuro-Oncology 1/2011

01-01-2011 | Letter to the Editor

Response to Dr. Nicholas Foray’s commentary on the paper by Rousseau et al. entitled “Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors”

Authors: Julia Rousseau, Rolf F. Barth, Manuel Fernandez, Jean-François Adam, François Estève, Hélène Elleaume

Published in: Journal of Neuro-Oncology | Issue 1/2011

Login to get access

Excerpt

First, let us point out the central point of agreement between Dr. Foray and ourselves. We all agree that the combination of photon irradiation and intracerebral (i.c.) delivery of cisplatin or carboplatin results in enhanced survival of F98 glioma bearing rats compared to each modality alone and that this therapeutic approach appears as promising for brain tumor treatment. Now let us turn to the areas of disagreement. …
Literature
1.
go back to reference Barth RF, Yang W, Huo T et al (2009) Enhanced survival and cure of F98 glioma bearing rats following convection enhanced delivery of carboplatin in combination with X-irradiation. Neuro-Oncology 11:590 Barth RF, Yang W, Huo T et al (2009) Enhanced survival and cure of F98 glioma bearing rats following convection enhanced delivery of carboplatin in combination with X-irradiation. Neuro-Oncology 11:590
2.
go back to reference Yang W, Huo T, Barth RF et al (2010) Convection enhanced delivery of carboplatin in combination with radiotherapy and for the treatment of brain tumors. J Neuro-Oncology (accepted) Yang W, Huo T, Barth RF et al (2010) Convection enhanced delivery of carboplatin in combination with radiotherapy and for the treatment of brain tumors. J Neuro-Oncology (accepted)
3.
go back to reference Rousseau J, Boudou C, Barth RF, Balosso J, Esteve F, Elleaume H (2007) Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res 13:5195–5201CrossRefPubMed Rousseau J, Boudou C, Barth RF, Balosso J, Esteve F, Elleaume H (2007) Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res 13:5195–5201CrossRefPubMed
4.
go back to reference Rousseau J, Barth RF, Moeschberger ML, Elleaume H (2009) Efficacy of intracerebral delivery of carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats. Int J Radiat Oncol Biol Phys 73:530–536CrossRefPubMed Rousseau J, Barth RF, Moeschberger ML, Elleaume H (2009) Efficacy of intracerebral delivery of carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats. Int J Radiat Oncol Biol Phys 73:530–536CrossRefPubMed
5.
go back to reference Bernhardt P, Friedland W, Paretzke HG (2004) The role of atomic inner shell relaxations for photon-induced DNA damage. Radiat Environ Biophys 43:77–84CrossRefPubMed Bernhardt P, Friedland W, Paretzke HG (2004) The role of atomic inner shell relaxations for photon-induced DNA damage. Radiat Environ Biophys 43:77–84CrossRefPubMed
6.
go back to reference Biston MC, Joubert A, Adam JF, Elleaume H, Bohic S, Charvet AM, Esteve F, Foray N, Balosso J (2004) Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res 64:2317–2323CrossRefPubMed Biston MC, Joubert A, Adam JF, Elleaume H, Bohic S, Charvet AM, Esteve F, Foray N, Balosso J (2004) Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res 64:2317–2323CrossRefPubMed
7.
go back to reference Corde S, Balosso J, Elleaume H, Renier M, Joubert A, Biston MC, Adam JF, Charvet AM, Brochard T, Le Bas JF, Esteve F, Foray N (2003) Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathways. Cancer Res 63:3221–3227PubMed Corde S, Balosso J, Elleaume H, Renier M, Joubert A, Biston MC, Adam JF, Charvet AM, Brochard T, Le Bas JF, Esteve F, Foray N (2003) Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathways. Cancer Res 63:3221–3227PubMed
8.
go back to reference Rousseau J, Barth RF, Fernandez M et al (2010) Efficacy of intracerebral delivery of cisplatin in combination with external photon irradiation for treatment of brain tumors. J Neuro-Oncology. doi:101007/s11060-009-0074-3 (in press) Rousseau J, Barth RF, Fernandez M et al (2010) Efficacy of intracerebral delivery of cisplatin in combination with external photon irradiation for treatment of brain tumors. J Neuro-Oncology. doi:101007/​s11060-009-0074-3 (in press)
9.
go back to reference Adam JF, Biston MC, Rousseau J, Boudou C, Charvet AM, Balosso J, Esteve F, Elleaume H (2008) Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment. Phys Med 24:92–97CrossRefPubMed Adam JF, Biston MC, Rousseau J, Boudou C, Charvet AM, Balosso J, Esteve F, Elleaume H (2008) Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment. Phys Med 24:92–97CrossRefPubMed
10.
go back to reference Adam JF, Joubert A, Biston MC, Charvet AM, Peoc’h M, Le Bas JF, Balosso J, Esteve F, Elleaume H (2006) Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 64:603–611CrossRefPubMed Adam JF, Joubert A, Biston MC, Charvet AM, Peoc’h M, Le Bas JF, Balosso J, Esteve F, Elleaume H (2006) Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 64:603–611CrossRefPubMed
11.
go back to reference Corde S, Joubert A, Adam JF, Charvet AM, Le Bas JF, Esteve F, Elleaume H, Balosso J (2004) Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds. Br J Cancer 91:544–551CrossRefPubMed Corde S, Joubert A, Adam JF, Charvet AM, Le Bas JF, Esteve F, Elleaume H, Balosso J (2004) Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds. Br J Cancer 91:544–551CrossRefPubMed
12.
go back to reference Rousseau J, Adam JF, Deman P, Wu TD, Guerquin-Kern JL, Gouget B, Barth RF, Esteve F, Elleaume H (2009) Intracerebral delivery of 5-iodo-2′-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma. J Synchrotron Radiat 16:573–581CrossRefPubMed Rousseau J, Adam JF, Deman P, Wu TD, Guerquin-Kern JL, Gouget B, Barth RF, Esteve F, Elleaume H (2009) Intracerebral delivery of 5-iodo-2′-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma. J Synchrotron Radiat 16:573–581CrossRefPubMed
13.
go back to reference Wu G, Yang W, Barth RF, Kawabata S, Swindall M, Bandyopadhyaya AK, Tjarks W, Khorsandi B, Blue TE, Ferketich AK, Yang M, Christoforidis GA, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA (2007) Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab. Clin Cancer Res 13:1260–1268CrossRefPubMed Wu G, Yang W, Barth RF, Kawabata S, Swindall M, Bandyopadhyaya AK, Tjarks W, Khorsandi B, Blue TE, Ferketich AK, Yang M, Christoforidis GA, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA (2007) Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab. Clin Cancer Res 13:1260–1268CrossRefPubMed
14.
go back to reference Yang W, Barth RF, Wu G, Ciesielski MJ, Fenstermaker RA, Moffat BA, Ross BD, Wikstrand CJ (2005) Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clin Cancer Res 11:341–350PubMed Yang W, Barth RF, Wu G, Ciesielski MJ, Fenstermaker RA, Moffat BA, Ross BD, Wikstrand CJ (2005) Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clin Cancer Res 11:341–350PubMed
15.
go back to reference Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ (2008) Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies. Clin Cancer Res 14:883–891CrossRefPubMed Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ (2008) Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies. Clin Cancer Res 14:883–891CrossRefPubMed
Metadata
Title
Response to Dr. Nicholas Foray’s commentary on the paper by Rousseau et al. entitled “Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors”
Authors
Julia Rousseau
Rolf F. Barth
Manuel Fernandez
Jean-François Adam
François Estève
Hélène Elleaume
Publication date
01-01-2011
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2011
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-010-0228-3

Other articles of this Issue 1/2011

Journal of Neuro-Oncology 1/2011 Go to the issue